MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fonc.2025.1528004

Медицинская библиотека · Frontiers in oncology · 2025

Combination of potassium oxonate with anti-PD-1 for the treatment of colorectal cancer.

Wang Yuanyuan, Hu Chenxi, Du Tianpeng, Li Jiawen, Hui Kaiyuan, Jiang Xiaodong

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Identification of effective therapies for colorectal cancer (CRC) remains an urgent medical need, especially for the microsatellite stable (MSS) phenotype. In our previous study, potassium oxonate (PO), a uricase inhibitor commonly used for elevating uric acid in mice, unexpectedly showed remarkable inhibition of tumor growth when combined with anti-programmed death-1 (PD-1). Further research demonstrated that the combination of potassium oxonate and anti-PD-1 could reprogram the immune microenvironment. This study aimed to explore the anti-tumor effect of PO combined with anti-PD-1, and investigate the impact on the immunosuppressive tumor microenvironment (TME).

METHODS

We established a syngeneic mouse model of CRC and divided into groups of control group, single drugs group of PO and anti-PD-1, and the combination group. Use the HE staining, immunohistochemistry (IHC) and TUNEL staining of tumor issues to verify the anti-neoplasm of each group. We also tested the changes of TME through flow cytometry of spleen of mice in each group, as well as the IHC of cytokines.

RESULTS

The co-therapy of PO and anti-PD-1 showed admirable anti-tumor effect compared with the control group and the single drug groups. The TME were tended to an environment beneficial for killing tumors by enhancing chemotactic factor release, increasing CD8+ T cell infiltration and activation, and decreasing the amount of regulatory T cells. Moreover, IFN-γ and IL-2 secretion were found to be enriched in the tumor TME.

CONCLUSION

Our study indicated that combination of PO and anti-PD-1 could synergistically suppress CRC progression and altered the tumor microenvironment in favor of antitumor immune responses.

Для цитирования: Wang Yuanyuan, Hu Chenxi, Du Tianpeng, Li Jiawen, Hui Kaiyuan, Jiang Xiaodong. Combination of potassium oxonate with anti-PD-1 for the treatment of colorectal cancer.. Frontiers in oncology. 2025. DOI: 10.3389/fonc.2025.1528004.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.